IRIX vs PACB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

IRIX

51.9
AI Score
VS
IRIX Wins

PACB

43.3
AI Score

Investment Advisor Scores

IRIX

52score
Recommendation
HOLD

PACB

43score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IRIX PACB Winner
Revenue 24.36M 76.19M PACB
Net Income -1.79M -53.02M IRIX
Gross Margin 37.1% 33.4% IRIX
Net Margin -7.3% -69.6% IRIX
Operating Income -1.35M -52.97M IRIX
ROE -49.2% 159.6% PACB
ROA -6.6% -7.1% IRIX
Total Assets 27.26M 751.85M PACB
Cash 4.68M 61.00M PACB
Current Ratio 1.82 4.92 PACB
Free Cash Flow -1.31M -84.87M IRIX

Relative Price Performance (Last 90 Days)

IRIX 1M: -10.8% · 3M: -42.6% PACB 1M: +92.4% · 3M: +53.0%

Current Technical Phase

IRIX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.3%), weak momentum, RSI 40

RSI (14): 39.9 · Price: $0.64

PACB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.1% over 20 days), RSI 86

RSI (14): 86.4 · Price: $2.54

Fundamentals Snapshot

Metric IRIX PACB
Market Cap — —
Forward P/E 769.2 -6.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.1% 0.0%
Gross Margin 0.4% 0.3%
Operating Margin -0.1% -1.1%
EPS -0.20 -0.44
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IRIX is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.